, there is substantial reason to conclude that the collaborative was of meaningful clinical value. For example, improvement was statistically significant in 4 of the 6 mean performance measures in the intervention group but in only 3 of 6 measures in the feedback-only (control) group. Moreover, improvement in the mean "all-or-none" measure was 15.6% greater in the intervention group than the control group, which exceeds the 15% difference sought in the power calculation for the primary outcome. Although that particular observed difference was not statistically significant, the upper bound of the CI for the all-or-none measure does not exclude a between-group advantage as great as 49% for the intervention group.
IN RESPONSE:
We thank Dr. Liu and colleagues for their comments regarding our recent article. They made several statements about our results that readers less familiar with the article may find misleading. Although both groups showed improvements in many aspects of antimicrobial prophylaxis, differences in the extent of improvement between the 2 groups on any indicator were not significant. Our conclusion is correct in this regard. Our study was designed to examine the absolute difference in change between the 2 groups, not the relative difference in change; thus, the proper statistic to evaluate the effect of participation in the collaborative group for the "all-ornone" indicator shows a 6.3% (95% CI, Ϫ7.3% to 19.8%) greater improvement in the active intervention.
We agree that improvement interventions are complex social processes that should be theory-based and explained in context by using evaluation models drawn from social science (1, 2) . However, we disagree with the statement that the real value of our study lies in the discovery of the heterogeneity and the opportunity for explaining it. Participants in all randomized studies, be they patients or organizations, exhibit heterogeneity. One of the greatest values of a randomized trial design is the ability to answer the question of effectiveness in the face of heterogeneity, thereby addressing the expectation of improvement for the next patient (or organization) that adopts the evaluated treatment. We agree that case studies of success can be extremely helpful in stimulating quality improvement, but the fact that we do not know which mechanisms worked within which circumstances does not negate the value of the cluster randomized trial as an evaluative methodology.
Annals of Internal Medicine
Letters Much needs to be done to improve the quality of health care delivery, and quality improvement collaboratives have a prominent role. In a recent systematic review of the impact of quality improvement collaboratives, Schouten and colleagues (3) concluded that the evidence of their effectiveness is encouraging but limited; they called for studies with a balance of both processoriented reports and rigorously controlled designs to understand why some collaboratives succeed while others have little effect on practice. Nevertheless, quality improvement collaboratives can be expensive to implement, and tightening resources require the selection of cost-effective strategies. Data from rigorous evaluations, such as that collected for TRAPE (Trial to Reduce Antimicrobial Prophylaxis Errors), are needed to help organizations select among potential improvement strategies.
Stephen B. Kritchevsky 
TO THE EDITOR:
The demonstration that all screening strategies recommended by the U.S. Preventive Services Task Force (USPSTF) are nearly equivalent for prevention of colorectal cancer mortality (assuming 100% adherence) is the most interesting aspect of the analysis by Zauber and colleagues (1, 2) . Differences in life-years gained between strategies for the MISCAN (Microsimulation Screening Analysis) model ranged from 227 to 230 life-years gained per 1000 persons, which is probably within the range of statistical error or small changes in model assumptions. In contrast, the differences in number of screening tests and volume of associated colonoscopy required between strategies differed widely, by as many as 7637 tests per 1000 persons and 786 colonoscopies per 1000 persons, respectively. These results raise a very important question: Are the relative expected life-year gains associated with a colonoscopy-only strategy enough to justify the movement in the United States toward favoring a more resource-intense and invasive "structural" examination-based approach to screening (3)?
Before answering this question, we must consider whether rates of adherence to screening are test-specific, such that differences in adherence may be more important for prediction of the best screening strategy than test-specific sensitivity for neoplasia. This issue can be appreciated by examining Figure 3 , in which it is clear that 80% adherence to Hemoccult SENSA (Beckman Coulter, Fullerton, California) provides better outcomes per 1000 persons than 50% adherence to colonoscopy (2 : We agree that an interesting finding from our analysis (1) for the USPSTF is that all the screening strategies now recommended by the USPSTF are nearly equivalent for life-years gained with screening when all have equivalent 100% adherence. We note that the USPSTF recommendation for the strategies of a highly sensitive guaiac or immunochemical fecal occult blood test (FOBT) annually, flexible sigmoidoscopy every 5 years with a sensitive FOBT, and colonoscopy every 10 years are based on the perspective of a program of screening from age 50 to 75 years with the end point of life-years gained rather than for screening at a point in time with the end point of reducing colorectal cancer incidence (2) . We also agree that the issue of adherence is a crucial component to the effectiveness of a screening intervention. The assumption of 100% adherence to all aspects of screening was used to provide a comparable assessment of potential efficacy for the different screening strategies and represents the best screening offer for those who adhere to testing, follow-up of positive findings, surveillance, and treatment. However, in clinical practice, adherence is very complex (and conLetters www.annals.orgsiderably less than 100%), with variation by screening test (3) and repeated screening. As shown in Figure 3 of our article (1), effectiveness of the intervention does vary by different levels of adherence. We noted that "in practice, adherence is critical and that ultimately the best option for a patient is the one that he or she will attend." We agree that it is important to ask what levels of relative adherence for colonoscopy and another screening test provide comparable levels of life-years gained per number of colonoscopies. We also agree that we need randomized, controlled trials to compare adherence and clinical outcomes after an invitation to participate in a colorectal cancer screening program using sensitive FOBT or colonoscopy. 
Ann G. Zauber, PhD

The Importance of Healing Skills in the Medical Home Concept
TO THE EDITOR: Many would readily agree with the findings of Churchill and Schenck (1), particularly those clinicians who routinely apply the relational (healing) skills described. But, for practicing physicians, the skills they mentioned require time-and a frame of mind unhindered by the need to see a disproportionate number of patients. Sadly, for many primary care doctors in particular, insurers' low remuneration rates and excessive administrative obligations have polluted the atmosphere for healing skills to survive. Keeping up with the science of medicine is difficult enough, but when the burden of administrative duties is added to the strain of financial survival, many physicians, although they profess to honor the relational skills described, will admit that they are deficient in applying them. It is ironic that new imaging techniques and new drugs, along with clinical guidelines that do improve patient care in one sense, also diminish the perception of the value of relational (healing) skills.
The point is, unless physicians make an effort to limit the number of patients they see in a day, they will not have the desire or the equanimity necessary to practice in the "healing" mode described by the authors. Using mid-level providers may provide some relief initially, but many physicians who employ them still complain that as their practices get bigger, so do the time constraints and patient demands. Many say their professionalism has turned into a treadmill existence. Any initial saving of time by physician assistants and nurse practitioners evaporates quickly as more patients enter a practice. As a physician who strives to use the skills mentioned by the authors, I have found the only way to achieve the composure needed to practice as a "healer" is to limit the number of patients I see in a day to 15 to 20.
Perhaps the skills the authors mentioned are not actually teachable. Maybe they are part of some medical students' psychological make-up and need to be assessed before students are admitted to medical schools. Another possibility is that after enduring the rigors of studying the basic sciences and the responsibilities of residency, many students' healing skills and humanitarian impulses simply shrivel and shrink, like a denervated limb.
It will be interesting to see how the importance of these skills is rated by patients, and how much these skills actually influence their clinical course. TO THE EDITOR: The healing skills identified by Churchill and Schenck (1) are vital to implementing continuity care "personal care" and a "whole-person orientation," 2 of the original 4 principles of a medical home described by Rogers (2) (the other 2 principles being team-directed medical practice and care that is coordinated and integrated). More recent iterations of the medical home concept, however, have moved from including reimbursement as a piece of the medical home (3) to translating "medical home" almost exclusively into a reimbursement concept. This article provides helpful documentation of the healing skills that must be the foundation of any conceptualization of what it means to build a medical home and a vital reminder to busy clinicians on what needs to be the focus of our day-to-day clinical practice. 
William E. Cayley, MD, MDiv
CLINICAL OBSERVATIONS
Mussel-Associated Azaspiracid Intoxication in the United States
Background: Azaspiracids (AZAs) are a group of structurally novel, heat-stabile marine toxins identified in mussels from Ireland following outbreaks of severe vomiting and diarrhea in Europe in 1995 and 1997 (1, 2). Azaspiracids accumulate in mussels and other bivalve mollusks that feed on toxic phytoplankton and vector organisms (3). Shellfish contaminated with AZAs have been documented in several European countries, including Ireland, Norway, and the United Kingdom (3).
Objective: To describe the first recognized cases of azaspiracid poisoning outside of Europe.
Case Report: Mussels harvested in Ireland and marketed in a cooked, frozen product consisting of mussels in a garlic and butter sauce (net weight, 1 lb) were heated and eaten by a husband and wife in Washington in July 2008. The husband ate approximately three quarters of the product, and the wife ate one quarter. Iced tea was the only other food ingested at the time. Five hours after eating the product, the couple experienced abdominal heaviness, vomiting (12 to 15 episodes for the husband, 5 to 10 for the wife), and profuse watery diarrhea for 24 to 30 hours. No medical treatment was sought. Two days later, the husband reported the illnesses to the U.S. Food and Drug Administration (FDA). The FDA purchased 5 packages of the product with the same lot number as that on the package the couple had bought and consumed. Analysis of the mussels for the presence of AZA (4) was conducted at FDA's Gulf Coast Seafood Laboratory in Dauphin Island, Alabama. The presence of AZA was determined by liquid chromatography-mass spectrometry/mass spectrometry in each product package as follows: 0.086, 0.115, 0.155, 0.117, and 0.244 mg/kg of mussel tissue. Two of these measures approached or exceeded the European Commission regulatory limit of 0.16 mg/kg (3). The couple recovered without long-term sequelae.
Discussion: Although meal remnants were not available for testing, we believe that AZA caused the couple's illness because symptoms were consistent with those of previous reports of azaspiracid poisoning and because the toxins were identified in mussels from multiple packages of the same product lot as that ingested. Levels of AZA have been shown to vary significantly among mussels harvested from a given region (5) , suggesting the concentration of toxins present in the mussels consumed exceeded the AZA regulatory limit. This report highlights the concern for the safety of foods marketed internationally from areas of disease endemicity.
Conclusion: Shellfish contaminated with AZA may be a cause of food-induced gastroenteritis in the United States. 
Carbon Dioxide-Induced Narcosis due to Dry Ice Exposure in a Patient With Sleep Apnea
Background: Dry ice is solid carbon dioxide. In enclosed spaces, evaporated carbon dioxide can displace oxygen to produce asphyxia.
Objective: To report a case of carbon dioxide-induced asphyxia after exposure to 500 lb of dry ice in an enclosed minivan.
Case Report: A 70-year-old, obese, nonsmoking male with a history of type 2 diabetes mellitus, hypertension, and obstructive sleep apnea for 3 years (treated with home continuous positive airway pressure) presented to an emergency department after being found unconscious in his minivan. He was revived with oxygen. The patient said that before losing consciousness he was "hyperventilating" but could not catch his breath. The sensation was associated with a bitemporal, throbbing headache and lightheadedness. He had been traveling in his minivan with the air conditioner on and the windows rolled up while transporting 500 lb of odorless dry ice, which was wrapped in brown paper in the rear area. His symptoms had occurred to a lesser degree several times when transporting smaller amounts (50 to 150 lb) of dry ice and were not associated with syncope.
On presentation to the emergency department, the patient was drowsy (after initiation of 100% oxygen) with a pulse of 95 beats/ min and a blood pressure of 93/55 mm Hg. Physical examination was unremarkable except for bilateral pitting edema below the knee. Laboratory examination was only remarkable for mild hyperglycemia and a leukocyte count of 18.5 ϫ 10 9 cells/L; this value normalized within 18 hours. Electrocardiographic examination was normal. The carboxyhemoglobin level was 1%. The patient's mental status normalized within 3 hours, and inpatient cardiovascular work-up (including echocardiography) was unremarkable. Computed axial tomography of the head was also unremarkable. The patient was discharged after a 2-day hospitalization. Discussion: Asphyxia occurs when atmospheric oxygen is less than 15%. This can occur with displacement of oxygen by a carbon dioxide concentration of 2000 ppm. Tokaoka and colleagues (1) describe a similar episode of carbon dioxide-induced asphyxia in a 37-year-old man exposed to 40 kg of dry ice in his car. In that report, the individual experienced seizures, pulmonary edema, and acidosis. We speculate that this patient's obstructive sleep apnea increased his susceptibility to toxicity from exposure to carbon dioxide and suggest that physicians caution patients with sleep apnea about the dangers of working with dry ice in enclosed environments (2) (3) (4) .
Conclusion: Dry ice can induce asphyxia in enclosed spaces, an effect that can be more pronounced in patients with preexisting respiratory disease, such as obstructive sleep apnea.
Mothball Mayhem: Relapsing Toxic Leukoencephalopathy due to p-Dichlorobenzene Neurotoxicity
Background: Aromatic hydrocarbons (such as toluene, n-hexane, and methyl butyl ketone) are volatile, lipid-soluble compounds found in various household and commercial products, such as aerosols, cleaning fluids, paints, and fuels. These substances are not identified as recreational drugs, but they are readily available and are commonly abused by sniffing (nasal inhalation) or huffing (oral inhalation). Symptoms due to inhalant abuse are similar to those resulting from central nervous system depressants, such as alcohol.
Because of its much lesser toxicity, p-dichlorobenzene (PDB) has replaced naphthalene as the primary component of mothballs. Both compounds have abuse potential. Inhalation and dermal absorptions are the common exposure routes. Toxicity is generally a consequence of accidental or occupational exposure. Toxicity rarely results from chronic ingestion (sucking or chewing) (1-4). Short-term ingestion of mothballs may be seen in the setting of pica (4) . The commonly recognized manifestations of PDB toxicity is hemolysis with methemoglobinemia and jaundice. Neurotoxicity related to PDB is very rare (1-5) . Cerebellar, extrapyramidal, cognitive, and pyramidal manifestations have been described. Diffuse leukoencephalopathy with progression to stupor, mutism, and coma has also been reported (4, 5) . Frank addiction may occur (1) . In some cases, withdrawal rather than use of PDB has been the suspected mechanism (3). In cases of clinical deterioration after abstinence, readministration and gradual taper of PDB may be a therapeutic option (3) .
Objective: To report a case of toxic leukoencephalopathy resulting from years of intermittent nasal inhalation and ingestion of mothballs.
Case Report: A 32-year-old woman with a history of bariatric surgery at age 27 years was hospitalized at our institution for a 1-year history of recurrent episodes of neurologic dysfunction characterized by subacute onset of dysarthria, ataxia, cognitive decline (at one point to catatonia), and skin scaling. Ninety percent improvement was noted after a past hospitalization, but the underlying diagnosis remained elusive, with no evidence of nutritional deficiencies or toxic exposures. After discharge to home, the patient's condition deteriorated, prompting hospitalization at our institution. She demonstrated clinically significant deficits: dementia, spastic and hypokinetic dysarthria, limb spasticity, bradykinesia, predominantly distal limb weakness, ataxia, and hyperreflexia. Ambulation without assistance was not possible. Magnetic resonance imaging showed diffuse increased T2 signal involving the cerebral white matter (Figure) . No cause was determined despite extensive investigations. She improved and was discharged to a local skilled-nursing facility where improvement continued. However, after transfer to another skilled-nursing facility closer to her home, she again deteriorated, prompting return to our institution.
We discovered that the patient had a history of chronic mothball sniffing starting as a child and progressing to ingestion approximately 2 years ago. After each hospitalization and before each episode of deterioration, she admitted resumption of ingestion of at least 1 mothball daily. The plasma PDB level, determined by gas chromatography, was elevated to 0.50 g/mL (detection threshold, 0.02 g/mL). The PDB level was rechecked after a subsequent relapse and was markedly elevated to 34 g/mL.
Discussion: Mothballs and other PDB-containing products (insect repellents, air fresheners, or toilet-bowl or diaper-pail deodorizers) are readily available and, as with other aromatic hydrocarbon-containing products, have recognized abuse potential. Toxicity from PDB commonly results in hematologic and dermatologic manifestations that can be additional diagnostic clues (2) . Rapid hepatic clearance of PDB and its metabolite 2,5-dichlorophenol is followed by accumulation in adipose tissue. Depletion of adipose tissue stores of these compounds is slow. Delayed deterioration after discontinuation of PDB use or an acute presentation may reflect release of the lipophilic toxin from fat reserves (4). The lipophilic nature is probably responsible for accumulation in and damage to myelin. Magnetic resonance imaging changes due to PDB toxicity may persist despite clinical improvement and reduction in PDB levels (4) .
Conclusion: Our case emphasizes that mothball inhalation and ingestion can lead to severe encephalopathy. This should be considered in the differential diagnosis of obscure encephalopathies and cerebellar disorders in all age groups.
